Literature DB >> 2436032

Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides.

I N Pessah, R A Stambuk, J E Casida.   

Abstract

The Ca2+-ryanodine receptor complex is a functional unit at the terminal cisternae (TC) of the sarcoplasmic reticulum (SR) whose proteins comprise the Ca2+ release channels which may be involved in excitation-contraction coupling. Ca2+, Mg2+, caffeine, and adenine nucleotides, but not inositol 1,4,5-trisphosphate, may exert their inotropic effects on skeletal muscle SR by direct allosteric modulation of the [3H]ryanodine-binding site. Micromolar Ca2+ is primarily responsible for activating [3H]ryanodine binding by regulating receptor site density, affinity, and cooperativity. Mg2+ reduces the sensitivity to Ca2+ activation by directly competing with Ca2+ for the activator site. However, inhibition by Mg2+ is overcome in the presence of beta,gamma-methyleneadenosine 5'-triphosphate (AMP-PCP; 1 mM) or caffeine (20 mM). Caffeine dramatically increases the affinity of the Ca2+ activator site for Ca2+, whereas AMP-PCP or cAMP enhances the gating efficiency or the lifetime of the open state of the TC SR channel. A kinetic model is proposed for four functional domains of the Ca2+-ryanodine receptor complex: the Ca2+-regulatory domain which binds Ca2+ with microM affinity is primarily responsible for gating the Ca2+ channel of the TC SR in a cooperative manner, and is inhibited by mM Mg2+ by direct competition for the activator site which appears to contain critical sulfhydryl groups; a Ca2+-activate alkaloid binding domain in close proximity to the channel which binds ryanodine with nM affinity and rapidly occludes upon complex formation; a domain which binds caffeine with low (greater than mM) affinity and directly influences the sensitivity of the Ca2+-regulatory site; and a domain which binds adenine nucleotides with intermediate affinity (less than mM), does not require phosphorylation, and intensifies the Ca2+ signal which triggers opening of the Ca2+-release channel.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436032

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  89 in total

1.  Sustained release of calcium elicited by membrane depolarization in ryanodine-injected mouse skeletal muscle fibers.

Authors:  Claude Collet; Vincent Jacquemond
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

2.  Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).

Authors:  G G Du; H Oyamada; V K Khanna; D H MacLennan
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Location of ryanodine and dihydropyridine receptors in frog myocardium.

Authors:  Pierre Tijskens; Gerhard Meissner; Clara Franzini-Armstrong
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

4.  Scorpion toxins targeted against the sarcoplasmic reticulum Ca(2+)-release channel of skeletal and cardiac muscle.

Authors:  H H Valdivia; M S Kirby; W J Lederer; R Coronado
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 5.  Ion conduction and discrimination in the sarcoplasmic reticulum ryanodine receptor/calcium-release channel.

Authors:  A J Williams
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

6.  Effects of 8-(N-N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) on skinned myocardial fibres of the rat: reversible inhibition of calcium release from the sarcoplasmic reticulum.

Authors:  S Takahashi; M Adachi; H Tanaka; K Shigenobu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

7.  Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function.

Authors:  P S Mushlin; B J Cusack; R J Boucek; T Andrejuk; X Li; R D Olson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2.

Authors:  Isaac N Pessah; Hans-Joachim Lehmler; Larry W Robertson; Claudio F Perez; Elaine Cabrales; Diptiman D Bose; Wei Feng
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

9.  4,6-Dibromo-3-hydroxycarbazole (an analogue of caffeine-like Ca2+ releaser), a novel type of inhibitor of Ca(2+)-induced Ca2+ release in skeletal muscle sarcoplasmic reticulum.

Authors:  Y Takahashi; K Furukawa; D Kozutsumi; M Ishibashi; J Kobayashi; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.